1. Adverse Drug Reaction Bullettin, 2002, 147, 587.
2. Barnes A.D. et al., Am. J. Clin. Pathol., 1996, 105 (3), 298.
3. Barretto M.G. et al., Rev. Assoc. Med. Bras., 2010, 56 (1), 51.
4. Belchikov Y.G., Marotta S.E., Pharmacotherapy, 2010, 30 (4), 134e.
5. Clark N.P., J. Thromb. Thrombolysis, 2009, 27 (3), 267.
6. Dolovich L.R. et al., Arch. Intern. Med., 2000, 160 (2), 181.
7. Drouet L. et al., Am. Heart J., 2009, 158 (2), 177.
8. Este J.W., Clin. Pharmacokin., 1980, 5, 204.
9. Ferreira Chacon J.M. et al., J. Tissue Viability, 2010, consultabile all’indirizzo: http://www.ncbi.nlm.nih.gov/pubmed/20409713
10. Follis F. et al., Interact. Cardiovasc. Thorac. Surg., 2010, 10 (4), 592.
11. Gomes O.M., Gomes E.S., Heart Surg. Forum, 2010, 13 (1), E49.
12. Greer I., Hunt B.J., Br. J. Haem., 2005, 128, 593.
13. Hommes D.W. et al., Ann. Int. Med., 1992, 116, 279.
14. Ignjatovic V. et al., J. Thromb. Haemost., 2010, 8 (6), 1290.
15. International Stroke Trial Collaborative Group, Lancet, 1997, 349, 1569.
16. Jacques L.B., Trends Pharmacol. Sci., 1982, 3, 289.
17. Levi M. et al., Am. J. Respir. Crit. Care Med., 2007, 176 (5), 483.
18. Lewis B.E. et al., Arch. Intern. Med., 2003, 163 (15), 1849.
19. Magee K.D. et al., Cochrane Database Of Systematic Reviews, 2003, 1, CD002132.
20. Marciniak E., J. Lab. Clin. Med., 1974, 84, 34.
21. N. Engl. J. Med., 1998, 338 (21), 1488.
22. Parodi G. et al., Am. J. Cardiol., 2010, 105 (8), 1053.
23. Prescrire Int., 2007, 16 (87), 16.
24. Rajgopal R. et al., Thromb. Res., 2008, 122 (3), 293.
25. Raschke R.A. et al., Ann. Int. Med., 1993, 119, 874.
26. Routledge P.A. et al., Br. J. Clin. Pharm., 1998, 46, 343.
27. Sanchez G., N. Engl. J. Med., 1975, 292 (1), 48.
28. Schindewolf M. et al., C.M.A.J., 2009, 181, 477.
29. Smith A.J. et al., Am. Heart J., 1996, 131, 434.
30. Ul'ianov A.M. et al., Izv Akad Nauk Ser Biol, 2010, (1), 109.
31. White H.D. et al., Circulation, 1997, 96 (7), 2155.